MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 264 filers reported holding MYRIAD GENETICS INC in Q1 2019. The put-call ratio across all filers is 2.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $293,000 | +8.9% | 10,230 | +5.7% | 0.01% | 0.0% |
| Q2 2019 | $269,000 | -12.7% | 9,680 | +4.5% | 0.01% | -14.3% |
| Q1 2019 | $308,000 | +14.5% | 9,262 | 0.0% | 0.01% | +16.7% |
| Q4 2018 | $269,000 | -36.9% | 9,262 | 0.0% | 0.01% | -33.3% |
| Q3 2018 | $426,000 | +31.5% | 9,262 | +6.9% | 0.01% | +28.6% |
| Q2 2018 | $324,000 | +26.6% | 8,668 | 0.0% | 0.01% | +16.7% |
| Q1 2018 | $256,000 | +1.6% | 8,668 | +18.3% | 0.01% | 0.0% |
| Q4 2017 | $252,000 | +13.5% | 7,326 | +19.4% | 0.01% | +20.0% |
| Q3 2017 | $222,000 | +66.9% | 6,138 | +19.2% | 0.01% | +66.7% |
| Q2 2017 | $133,000 | +146.3% | 5,148 | +82.8% | 0.00% | +200.0% |
| Q1 2017 | $54,000 | – | 2,816 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |